

Medifus, the AI that redefines biomedicine
Medifus is the world's first intelligent molecular biomedicine AI platform, developed by Mediot AI, which unifies clinical data, research, pharmacopoeia, and automation to improve the accuracy, personalization, and accessibility of medical decisions.
The first platform to merge clinical, molecular biomedicine, and intelligent pharmacopoeia
Medifus marks a major breakthrough in the history of digital health: it is the first technology capable of connecting, within a unique system, clinical data, biological data, medical research, and natural pharmacopoeia, all orchestrated by biomedical artificial intelligence agents.
The platform transforms raw data into personalized therapeutic protocols, validated by simulations of virtual patients and advanced predictive models. This innovation, documented and operational, has already led to the filing of international patents in strategic fields such as cardio-nephro-endocrinology, psychonutrition, fertility, high-risk pregnancies, and precision phytotherapy.
Four pillars to cover the entire continuum of care and decision-making
Medifus relies on an integrated modular architecture designed to meet the needs of clinicians, researchers, public authorities, and health decision-makers.
It is structured around four complementary modules:
Medifus Clinical™: real-time clinical intelligence, risk detection, analysis of drug-plant-supplement interactions, and generation of personalized protocols.
Medifus Research Lab™: accelerator for medical research through AI, automating hypothesis generation, cohort analysis, and scientific synthesis.
Medifus Public Health™: AI tool dedicated to national health programs, population modeling, and early detection of health risks.
Medifus Insight Studio™: strategic cockpit for health governance, health economics, and large-scale decision-making.
Together, these modules constitute a true Health Intelligence Operating System.
Toward a sustainable, fair, and connected model of care
Beyond technological innovation, Medifus embodies a strong vision: to reduce inequalities in access to healthcare, strengthen the autonomy of communities, and build a sustainable model of connected health, particularly on the African continent.
In a context where millions of people remain without reliable diagnostics, the platform aims to democratize access to high-precision medical analyses through the convergence of artificial intelligence, intelligent diagnostics, and distributed connectivity. This approach paves the way for a new generation of care pathways: earlier, more informed, and guided by AI for a sustainable health impact.



